The impact of COVID-19 on hospitalization outcomes of patients with acute myocardial infarction in the USA.
Acute myocardial infarction
COVID-19
Cardiovascular diseases
Mortality
Pandemic
Journal
American heart journal plus : cardiology research and practice
ISSN: 2666-6022
Titre abrégé: Am Heart J Plus
Pays: United States
ID NLM: 101779333
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
08
03
2023
revised:
21
05
2023
accepted:
24
05
2023
medline:
20
6
2023
pubmed:
20
6
2023
entrez:
20
6
2023
Statut:
ppublish
Résumé
The effect of the COVID-19 pandemic affected health care delivery, as it led to variable outcomes in different disease states including cardiovascular diseases. In this study, we evaluated the impact of coexisting COVID-19 on Acute Myocardial Infarction (AMI). We analyzed discharge records of AMI patients from the National Inpatient Sample (NIS) in the year 2020. Using propensity score matching, we assessed the impact of COVID-19 infection on the in-hospital outcomes of patients presenting with AMI. There were 1154 patients with concomitant COVID-19 infection and AMI who were matched with 109,990 patients with AMI and without COVID-19. We found that patients with COVID-19 who had AMI were less likely to have dyslipidemia (64.6 % vs. 70.4 %, COVID-19 infection is associated with worse in-hospital mortality and cardiorespiratory complications in patients with AMI.
Sections du résumé
Background/study objective
UNASSIGNED
The effect of the COVID-19 pandemic affected health care delivery, as it led to variable outcomes in different disease states including cardiovascular diseases. In this study, we evaluated the impact of coexisting COVID-19 on Acute Myocardial Infarction (AMI).
Design/setting
UNASSIGNED
We analyzed discharge records of AMI patients from the National Inpatient Sample (NIS) in the year 2020.
Main outcome measures
UNASSIGNED
Using propensity score matching, we assessed the impact of COVID-19 infection on the in-hospital outcomes of patients presenting with AMI.
Results
UNASSIGNED
There were 1154 patients with concomitant COVID-19 infection and AMI who were matched with 109,990 patients with AMI and without COVID-19. We found that patients with COVID-19 who had AMI were less likely to have dyslipidemia (64.6 % vs. 70.4 %,
Conclusion
UNASSIGNED
COVID-19 infection is associated with worse in-hospital mortality and cardiorespiratory complications in patients with AMI.
Identifiants
pubmed: 37337595
doi: 10.1016/j.ahjo.2023.100305
pii: S2666-6022(23)00057-5
pmc: PMC10258131
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100305Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
JAMA. 2021 Nov 16;326(19):1940-1952
pubmed: 34714327
J Cardiovasc Pharmacol. 2020 Nov;76(5):540-548
pubmed: 33170591
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):476-480
pubmed: 34913208
PLoS One. 2021 Jul 1;16(7):e0253580
pubmed: 34197488
J Cardiovasc Pharmacol Ther. 2021 Sep;26(5):399-414
pubmed: 33949887
Am J Cardiol. 2021 Jul 1;150:69-76
pubmed: 34001343
Biom J. 2017 Sep;59(5):967-985
pubmed: 28436047
Nat Rev Cardiol. 2020 Sep;17(9):543-558
pubmed: 32690910
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
J Clin Med. 2020 May 06;9(5):
pubmed: 32384601
Front Cardiovasc Med. 2022 Sep 22;9:917250
pubmed: 36211554
Crit Care Med. 2015 Sep;43(9):1870-9
pubmed: 26086943
Am J Cardiol. 2021 Feb 15;141:140-146
pubmed: 33217345
Health Serv Res. 2014 Feb;49(1):284-303
pubmed: 23855598
JAMA Cardiol. 2020 Dec 1;5(12):1419-1424
pubmed: 32766756
J Causal Inference. 2015 Sep;3(2):237-249
pubmed: 29430383